Quarterly report pursuant to Section 13 or 15(d)

INVESTMENT IN MYMD PHARMACEUTICALS, INC. (Tables)

v3.24.3
INVESTMENT IN MYMD PHARMACEUTICALS, INC. (Tables)
3 Months Ended
Jul. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Summary of investment stock and warrants

Summary of investment stock and warrants

Balance of Preferred Stock as of April 30, 2024   $  
Purchased     17,410,050  
Change in fair value     966,950  
Balance of Warrant assets as of July 31, 2024   $ 18,377,000  

 

Below is a summary of activity for the Preferred Stock Warrants as of July 31, 2024:

Balance of Warrant assets as of April 30, 2024   $  
Purchased     10,985,684  
Change in fair value     (242,684)  
Balance of Warrant assets as of July 31, 2024   $ 10,743,000